6 Related NICE guidance
Published
-
Ipilimumab for previously treated advanced (unresectable or metastatic) malignant melanoma. NICE technology appraisal guidance 268 (2012).
-
Skin cancer prevention: information, resources and environmental changes. NICE public health guidance 32 (2011).
-
Improving outcomes for people with skin tumours including melanoma. NICE cancer service guidance (2006).
-
Referral guidelines for suspected cancer. NICE clinical guideline 27 (2005).
-
Improving supportive and palliative care for adults with cancer. NICE cancer service guidance (2004).
Under development
NICE is developing the following guidance:
-
Ipilimumab in combination with dacarbazine for previously untreated unresectable stage III or IV malignant melanoma (expected date of publication August 2013).